Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

The Lancet Oncology
The Lancet Oncology, 21(6), 750-751. Lancet Publishing Group
lancet oncology, 21(6), 750-751. Lancet Publishing Group
The Lancet. Oncology
Lancet Oncology, 21(6), 750-751. ELSEVIER SCIENCE INC
Lancet Oncology, 21, 750-751
Dinmohamed, A G, Visser, O, Verhoeven, R H A, Louwman, M W J, van Nederveen, F H, Willems, S M, Merkx, M A W, Lemmens, V E P P, Nagtegaal, I D & Siesling, S 2020, ' Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands ', The Lancet Oncology, vol. 21, no. 6, pp. 750-751 . https://doi.org/10.1016/S1470-2045(20)30265-5
Lancet Oncology, 21, 6, pp. 750-751
Lancet oncology, 21(6), 750-751. Lancet Publishing Group

2019-20 coronavirus outbreak; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pneumonia, Viral; Medical Oncology; Article; Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]; Betacoronavirus; General Practitioners; Neoplasms; Pandemic; Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]; medicine; Humans; Medical diagnosis; Pandemics; Early Detection of Cancer; Netherlands; business.industry; SARS-CoV-2; 22/2 OA procedure; Cancer; COVID-19; medicine.disease; Oncology; Neoplasms diagnosis; business; Coronavirus Infections; Delivery of Health Care; Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]; Demography

English